A thread on key takeaways from #BalajiAmines Annual Report-2022.
Courtesy @ash_lodha
👉Business blueprint since beginning:
1) Focus on import substitute products.
2) Use local technology to develop & manufacture products.
3) Alter design & processes to make products cost effective.
👉Largest Indian producer of the following products:
• Methylamines
• Ethylamines
• Di-Methyl Acetamide (DMAC)
• Di-Methyl Amine Hydrochloride (DMA HCL)
• Dimethylformamide (DMF)
👉Sole Manufacturer in India for the following products:
• Morpholine
• Dimethylformamide (DMF)
• N-Ethyl-2-Pyrrolidone (NEP)
• N-Methyl-Pyrrolidone (NMP)
• Pharmapure Povidone
• Pharmapure Povidone (PVP K30 & PVP K25)
• Gamma Butyrolactone (GBL)
👉Competitive Advantage:
• Fully Automated plants controlled through DCS System.
• Only company to use indigenous technology to manufacture amines & allied products.
• Global presence in > 50 countries & > 1200 customers
• All facilities are zero liquid discharge units.
👉Product wise Performance
👉Key Numbers:
👉Key Ratio’s:
👉Takeaway from Chairman's Speech:
👉Capex Blueprint:
👉Management Discussion & Analysis
👉Management Discussion & Analysis
📝Balaji Specialty Chemical Ltd (BSCL)- subsidiary of Balaji Amines Ltd:
👉Financial performance of Balaji Specialty Chemical Ltd (BSCL).
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.